DekaBank Deutsche Girozentrale’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-72,697
| Closed | -$2.15M | – | 1532 |
|
|
2023
Q4 | $2.15M | Buy |
72,697
+2,797
| +4% | +$55.7K | ﹤0.01% | 760 |
|
|
2023
Q3 | $1.11M | Hold |
69,900
| – | – | ﹤0.01% | 856 |
|
|
2023
Q2 | $1.31M | Hold |
69,900
| – | – | ﹤0.01% | 835 |
|
|
2023
Q1 | $255K | Hold |
69,900
| – | – | ﹤0.01% | 1148 |
|
|
2022
Q4 | $355K | Hold |
69,900
| – | – | ﹤0.01% | 1118 |
|
|
2022
Q3 | $323K | Hold |
69,900
| – | – | ﹤0.01% | 1128 |
|
|
2022
Q2 | $300K | Hold |
69,900
| – | – | ﹤0.01% | 1121 |
|
|
2022
Q1 | $332K | Buy |
69,900
+6,400
| +10% | +$35.4K | ﹤0.01% | 1132 |
|
|
2021
Q4 | $473K | Buy |
63,500
+1,500
| +2% | +$9.32K | ﹤0.01% | 1111 |
|
|
2021
Q3 | $349K | Hold |
62,000
| – | – | ﹤0.01% | 1118 |
|
|
2021
Q2 | $401K | Hold |
62,000
| – | – | ﹤0.01% | 1112 |
|
|
2021
Q1 | $496K | Hold |
62,000
| – | – | ﹤0.01% | 1033 |
|
|
2020
Q4 | $402K | Buy |
+62,000
| New | +$362K | ﹤0.01% | 1062 |
|
|
2019
Q3 | – | Sell |
-90,200
| Closed | -$185K | – | 1148 |
|
|
2019
Q2 | $185K | Buy |
90,200
+35,100
| +64% | +$83K | ﹤0.01% | 1022 |
|
|
2019
Q1 | $562K | Buy |
55,100
+10,000
| +22% | +$43.3K | ﹤0.01% | 885 |
|
|
2018
Q4 | $201K | Sell |
45,100
-10,000
| -18% | -$60.7K | ﹤0.01% | 966 |
|
|
2018
Q3 | $562K | Sell |
55,100
-1,500
| -3% | -$14.4K | ﹤0.01% | 905 |
|
|
2018
Q2 | $564K | Hold |
56,600
| – | – | ﹤0.01% | 881 |
|
|
2018
Q1 | $608K | Buy |
+56,600
| New | +$559K | ﹤0.01% | 832 |
|
|
2016
Q2 | – | Sell |
-37,700
| Closed | -$311K | – | 1056 |
|
|
2016
Q1 | $311K | Sell |
37,700
-6,500
| -15% | -$55K | ﹤0.01% | 754 |
|
|
2015
Q4 | $604K | Buy |
44,200
+800
| +2% | +$9.85K | 0.01% | 658 |
|
|
2015
Q3 | $417K | Buy |
43,400
+1,500
| +4% | +$21.9K | 0.01% | 728 |
|
|
2015
Q2 | $603K | Buy |
41,900
+1,700
| +4% | +$18.7K | 0.01% | 668 |
|
|
2015
Q1 | $360K | Sell |
40,200
-6,000
| -13% | -$43.5K | ﹤0.01% | 790 |
|
|
2014
Q4 | $278K | Sell |
46,200
-4,000
| -8% | -$36.6K | ﹤0.01% | 808 |
|
|
2014
Q3 | $532K | Buy |
50,200
+1,000
| +2% | +$11.3K | 0.01% | 644 |
|
|
2014
Q2 | $583K | Sell |
49,200
-3,300
| -6% | -$41.4K | 0.01% | 580 |
|
|
2014
Q1 | $784K | Buy |
52,500
+4,000
| +8% | +$63.1K | 0.01% | 514 |
|
|
2013
Q4 | $731K | Buy |
48,500
+1,300
| +3% | +$20K | 0.01% | 494 |
|
|
2013
Q3 | $803K | Buy |
+47,200
| New | +$830K | 0.01% | 469 |
|
Other funds holding IMGN
DekaBank Deutsche Girozentrale's IMGN Position: Q1 2024 in Review
DekaBank Deutsche Girozentrale sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 72,697 shares — an estimated $2.15M sold.
DekaBank Deutsche Girozentrale first reported a position in IMGN in Q3 2013 and held it in 30 quarters. The position peaked at $2.15M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- DekaBank Deutsche Girozentrale reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 72,697 Immunogen Inc shares in Q1 2024, an estimated $2.15M.
- DekaBank Deutsche Girozentrale first reported a position in Immunogen Inc in Q3 2013 and held it in 30 quarters.
- DekaBank Deutsche Girozentrale's Immunogen Inc position peaked at $2.15M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2024, filed 24 Apr 2024.